Add to ORKGAlthough gastric cancer (GC) incidence and mortality rates have shown a consistent decline over several decades in most countries, GC is still one of the common cancers worldwide, accounting for about 8 % of new cancer
Background: To evaluate the relationship between methylation status of blood leukocyte DNA and risk ...
According to the estimations of the International Agency for Research on Cancer (IARC) in 2012, gast...
Gastric cancer is a highly aggressive and lethal malignancy. It accounts for 8.6 % of new cancer cas...
gene in gastric cancer ai common malignancies in the world. Disease development in gastric cancer is...
AIM: Hypermethylation of the promoter of the hMLH1 gene, which plays an important role in mismatch r...
Gastric carcinoma (GC) has one of the highest mortality rates of cancer diseases and has a high inci...
Despite the progressive decrease observed in the past fifty years, gastric cancer (GC) is the fourt...
DNA repair and apoptosis are two main pathways supporting the integrity of human genome. After the d...
Gastric cancer was one kind of tumors that originates in any part of the stomach. Currently the four...
Gastric cancer (GC), the second most common cause of cancer-related death in the world, can develop ...
Gastric cancer is the fourth most commonly diagnosed cancer worldwide and remains second only to lun...
Gastric cancer remains a global health problem. It is still a very common tumour type in Asia, but t...
Silencing-specific methylation and single nucleotide polymorphism of hMLH1 promoter in gastric carci...
DNA hypermethylation is the most important epigenetic alteration in the malignant transformation. It...
Cancer, particularly gastric cancer (GC), is prevalently an epigenetic phenomenon that is dependent ...
Background: To evaluate the relationship between methylation status of blood leukocyte DNA and risk ...
According to the estimations of the International Agency for Research on Cancer (IARC) in 2012, gast...
Gastric cancer is a highly aggressive and lethal malignancy. It accounts for 8.6 % of new cancer cas...
gene in gastric cancer ai common malignancies in the world. Disease development in gastric cancer is...
AIM: Hypermethylation of the promoter of the hMLH1 gene, which plays an important role in mismatch r...
Gastric carcinoma (GC) has one of the highest mortality rates of cancer diseases and has a high inci...
Despite the progressive decrease observed in the past fifty years, gastric cancer (GC) is the fourt...
DNA repair and apoptosis are two main pathways supporting the integrity of human genome. After the d...
Gastric cancer was one kind of tumors that originates in any part of the stomach. Currently the four...
Gastric cancer (GC), the second most common cause of cancer-related death in the world, can develop ...
Gastric cancer is the fourth most commonly diagnosed cancer worldwide and remains second only to lun...
Gastric cancer remains a global health problem. It is still a very common tumour type in Asia, but t...
Silencing-specific methylation and single nucleotide polymorphism of hMLH1 promoter in gastric carci...
DNA hypermethylation is the most important epigenetic alteration in the malignant transformation. It...
Cancer, particularly gastric cancer (GC), is prevalently an epigenetic phenomenon that is dependent ...
Background: To evaluate the relationship between methylation status of blood leukocyte DNA and risk ...
According to the estimations of the International Agency for Research on Cancer (IARC) in 2012, gast...
Gastric cancer is a highly aggressive and lethal malignancy. It accounts for 8.6 % of new cancer cas...